Literature DB >> 21983493

Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.

Davide Bruno1, Nunzio Pomara, Jay Nierenberg, James C Ritchie, Michael W Lutz, Henrik Zetterberg, Kaj Blennow.   

Abstract

Neurofilament light (NFL) proteins in cerebrospinal fluid (CSF) are a marker of neuronal damage, especially subcortical axonal injury and white matter disease. Subjects with Alzheimer's disease (AD) have shown elevated levels of CSF NFL as compared to controls. However, the presence of the APOE ε4 allele, an established risk factor for AD, was not found to associate with higher CSF NFL concentrations. We examined whether TOMM40 variants, which have been reported to influence age of onset of AD and are in linkage disequilibrium with APOE, have an effect on CSF NFL levels, in 47 healthy, cognitively intact individuals with or without APOE ε4. Our results show that the presence of APOE ε4 alone does not affect CSF NFL levels significantly; however APOE and TOMM40 appear to interact. Subjects with APOE ε4 have higher CSF NFL levels than non-ε4 carriers, only when they do not carry a short poly-T variant of TOMM40, which is associated with later age of onset of AD, and may act as protective against the dose effect of ε4.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983493      PMCID: PMC4550703          DOI: 10.1016/j.exger.2011.09.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  30 in total

1.  Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.

Authors:  Davide Bruno; Jay J Nierenberg; James C Ritchie; Michael W Lutz; Nunzio Pomara
Journal:  Psychoneuroendocrinology       Date:  2011-07-30       Impact factor: 4.905

2.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Authors:  K Blennow; A Wallin; H Agren; C Spenger; J Siegfried; E Vanmechelen
Journal:  Mol Chem Neuropathol       Date:  1995-12

3.  Neurochemical aftermath of amateur boxing.

Authors:  Henrik Zetterberg; M Albert Hietala; Michael Jonsson; Niels Andreasen; Ewa Styrud; Ingvar Karlsson; Ake Edman; Cornel Popa; Abdullah Rasulzada; Lars-Olof Wahlund; Pankaj D Mehta; Lars Rosengren; Kaj Blennow; Anders Wallin
Journal:  Arch Neurol       Date:  2006-09

4.  Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

Authors:  L E Rosengren; J E Karlsson; J O Karlsson; L I Persson; C Wikkelsø
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

5.  Neurofilament protein levels in CSF are increased in dementia.

Authors:  L E Rosengren; J E Karlsson; M Sjögren; K Blennow; A Wallin
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

6.  Elevated neurofilament levels in neurological diseases.

Authors:  Niklas Norgren; Lars Rosengren; Torgny Stigbrand
Journal:  Brain Res       Date:  2003-10-10       Impact factor: 3.252

7.  Is there a CSF biomarker profile related to depression in elderly women?

Authors:  Pia Gudmundsson; Ingmar Skoog; Margda Waern; Kaj Blennow; Henrik Zetterberg; Lars Rosengren; Deborah Gustafson
Journal:  Psychiatry Res       Date:  2010-02-04       Impact factor: 3.222

8.  Neurofilament gene expression: a major determinant of axonal caliber.

Authors:  P N Hoffman; D W Cleveland; J W Griffin; P W Landes; N J Cowan; D L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

Authors:  Maria Bjerke; Ulf Andreasson; Sindre Rolstad; Arto Nordlund; Karin Lind; Henrik Zetterberg; Ake Edman; Kaj Blennow; Anders Wallin
Journal:  Dement Geriatr Cogn Disord       Date:  2009-10-27       Impact factor: 2.959

10.  Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease.

Authors:  Changiz Geula; Nicholas Nagykery; Alexander Nicholas; Chuang-Kuo Wu
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

View more
  13 in total

1.  The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

Authors:  William K Gottschalk; Michael W Lutz; Yu Ting He; Ann M Saunders; Daniel K Burns; Allen D Roses; Ornit Chiba-Falek
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-11

Review 2.  The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.

Authors:  Ornit Chiba-Falek; William K Gottschalk; Michael W Lutz
Journal:  Alzheimers Dement       Date:  2018-03-07       Impact factor: 21.566

3.  TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype.

Authors:  Lei Yu; Michael W Lutz; Robert S Wilson; Daniel K Burns; Allen D Roses; Ann M Saunders; Chris Gaiteri; Philip L De Jager; Lisa L Barnes; David A Bennett
Journal:  Neurology       Date:  2017-01-20       Impact factor: 9.910

4.  A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.

Authors:  Davide Bruno; Michel J Grothe; Jay Nierenberg; Henrik Zetterberg; Kaj Blennow; Stefan J Teipel; Nunzio Pomara
Journal:  Neuropsychologia       Date:  2015-01-19       Impact factor: 3.139

5.  The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.

Authors:  Colton Linnertz; Lauren Anderson; William Gottschalk; Donna Crenshaw; Michael W Lutz; Jawara Allen; Sunita Saith; Mirta Mihovilovic; James R Burke; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2014-01-15       Impact factor: 21.566

6.  Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population.

Authors:  Xiao-Ying Ma; Jin-Tai Yu; Wei Wang; Hui-Fu Wang; Qiu-Yan Liu; Wei Zhang; Lan Tan
Journal:  Neuromolecular Med       Date:  2013-01-04       Impact factor: 3.843

7.  Regulation of Prdx6 by Nrf2 Mediated Through aiPLA2 in White Matter Reperfusion Injury.

Authors:  Amita Daverey; Sandeep K Agrawal
Journal:  Mol Neurobiol       Date:  2020-11-06       Impact factor: 5.590

8.  TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.

Authors:  Andreas Bender; Paula Desplats; Brian Spencer; Edward Rockenstein; Anthony Adame; Matthias Elstner; Christoph Laub; Sarina Mueller; Andrew O Koob; Michael Mante; Emily Pham; Thomas Klopstock; Eliezer Masliah
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age.

Authors:  Beata Ferencz; Erika J Laukka; Martin Lövdén; Grégoria Kalpouzos; Lina Keller; Caroline Graff; Lars-Olof Wahlund; Laura Fratiglioni; Lars Bäckman
Journal:  Front Hum Neurosci       Date:  2013-05-22       Impact factor: 3.169

10.  Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

Authors:  D M Lyall; S E Harris; M E Bastin; S Muñoz Maniega; C Murray; M W Lutz; A M Saunders; A D Roses; M del C Valdés Hernández; N A Royle; J M Starr; D J Porteous; J M Wardlaw; I J Deary
Journal:  Transl Psychiatry       Date:  2014-09-23       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.